After decades of research, development & clinical use, proton therapy is fulfilling its considerable promise for cancer patients.
There are currently many proton therapy centers in development or under construction. Some scientists have referred to proton therapy as the “holy grail” of all radiotherapies because of the beam’s ability to precisely target tumors and spare radiation effects to surrounding healthy cells and tissue. It has been the dream of many radiation oncologists to have access to a proton beam. Proton therapy is no longer the best kept secret in cancer treatment. That it is fulfilling its promise and has a bright future.
More precise dose delivery, fewer side effects, better results—Proton Therapy is changing the way cancer is treated. Ground- breaking innovations and flexible solutions are making Proton Therapy a reality for more doctors, more communities and more patients.
After our two consecutive successful Proton therapy events, we invite you to attend our Third National Conference on Planning, Building and Operating Successful Proton Therapy Centers” February 20-22, 2013 in San Diego, California. This conference will focus on planning, developing, building and operating Proton Therapy facilities to bring the leading edge of cancer treatment to more patients.
We want to thank the Scripps Proton Therapy Center for hosting this 3nd annual ACI conference on Planning, Building and Oper- ating Successful Proton Therapy Centers. Join us in San Diego February 20-23, 2013 for this exciting industry conference!
The 102,000-square-foot Scripps Proton Therapy Center will be the first in San Diego County and one of only 10 nationwide to offer proton therapy. Expected to attract patients from across the West, the center enhances the range of cancer care services available at Scripps Cancer Center. When the center opens in 2013, Scripps will provide the most comprehensive range of radiation therapy options available and have the capacity to treat 2,400 patients every year.
The new facility will include:
In addition to providing patient care, Scripps expects to be at the forefront of new and developing clinical applications as part of its proton practice and connection with other national centers. The proton system will be provided by Varian Medical Systems and the facility is being developed and operated through a collaboration among Scripps Health, Scripps Clinic Medical Group and Advanced Particle Therapy, LLC, of San Diego.
The conference is ideally suited for administrators and other health care professionals involved in the care of Oncology patients – Representing the Oncology. Oncology Imaging, Radiology Departments of Community Hospitals, Health Systems, Academic Medical Centers, and Hospital Networks.
IBA develops, manufactures and supports medical devices and software solutions for cancer treatment by proton beam therapy, for cancer diagnosis and for patient quality assurance (Dosimetry).
In addition, the company partners with healthcare leaders to provide cancer clinics and academic health centers with a fully-integrated approach of the patient flow. Today, IBA solutions in oncology are used in over 3,000 hospitals worldwide.
Its expertise in particle accelerators enables IBA to provide also sterilization and ionization solutions for the industry. Headquartered in Belgium, IBA operates in more than 40 countries in North America, Europe & Asia. IBA is listed on the pan-European stock exchange EURONEXT.
Organizations of every size and sector ponder this question every day. For some, the answer may lie in a new or expanded facility. For others, the solution may be new engineering processes designed to fuel a growing supply chain.
Haskell provides fully integrated facility solutions that ensure the effective execution of capital projects across multiple markets. Our leadership in design-build, construction management and EPC delivery methods has led to the successful completion of thousands of projects worldwide.
C-RAD AB is a holding company with three subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. The parent company is responsible for economy, accounting and marketing and sales of the company’s products and solutions. All product development is done in the different subsidiaries. Through detailed knowledge about the radiotherapy business and its customer requirements we shall offer products for positioning, monitoring, tumor localization and radiation therapy. Our customers are radiation treatment clinics and diagnostics departments in hospitals worldwide. The aim is to contribute to higher level of quality and efficiency at the customer.
APT provides a fully integrated solution for the development of proton treatment centers for leading academic medical institutions as well as premier regional healthcare systems. APT serves as the project’s developer and provides a turnkey solution to the highly complex task of successfully developing, designing, constructing, overseeing and managing a particle therapy treatment center.
From proton therapy center design-build services to market analysis and equipment planning, Advanced Particle Therapy manages every aspect of proton therapy cancer center development. Advanced Particle Therapy has the equipment, the esteemed strategic partners and the materials necessary to keep every proton therapy project running according to plan.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops advanced tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the cancer care spectrum. Through its products and services, Elekta aims to improve, prolong and save patient lives. Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals globally. Elekta, with corporate headquarters in Stockholm, Sweden, employs approximately 3,000 people globally.
VOA Associates Incorporated is committed to delivering remarkable client service and award-winning design for the built environment. Founded by Wilmont Vickrey in 1969, we have always been driven by three core values: partnering with clients, developing a humanistic approach to great design, and creating a nurturing culture that attracts the very best people and talent.
We listen, understand client needs, integrate our expertise, and deliver effective and efficient solutions. The result is distinctive, acclaimed spaces that enhance the environment and improve the human experience—places for people to heal, learn, work, and play.
Varian Medical Systems is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.
Mevion Medical Systems, Inc. is the pioneering developer of modern proton therapy systems. Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical reality. Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide.
With 620 lawyers in 12 offices nationwide, we strive to provide clients with unparalleled service in matters ranging from billion-dollar deals to complex class actions, across a broad spectrum of industries. Our priorities are knowing our clients’ business and providing the value they need so that we can be an integral part of their success. Clients choose us for our sophisticated yet efficient approach to handling their most important business transactions, litigation and government affairs efforts. Our 160-plus year history is marked by service to the public and the bar and innovating for our clients.
Veritas Medical Solutions manufactures pre-engineered radiation shielding systems designed for fast and efficient modular construction of proton therapy centers ranging from large multi-room facilities to smaller single treatment room designs. Equipment-specific shielding designs are available for all major machine types and utilize innovative VeriShield TM radiation shielding modules and groundbreaking Veritas bi-parting radiation shielded entry doors. Veritas bi-parting Proton doors represent the world’s first direct entry door system for use in proton facilities, and have been successfully installed at the Provision Center for Proton Therapy in Knoxville, TN.
With Accelitech, accessing the latest technology and creating a successful specialty program is fast and easy. By working with us as partners, physicians and hospitals can acquire the latest technology and develop successful healthcare programs in an accelerated time frame. As a vendor-neutral company, we can apply our full-cycle management model to virtually any healthcare technology, getting the latest treatment to the most patients in the places it will do the most good.
DOTmed.com is the world’s leading public platform for buying and selling medical equipment, parts and services — we welcome more than 20,000 unique visitors every day. DOTmed was founded in 1999 as an open marketplace for healthcare professionals, medical equipment manufacturers, brokers, and dealers, and today have we have more than 210,000 registered users. Many of the original features on DOTmed.com were free, and still are today. You can register for free, post classified ads, browse, and read our Online News — all for free. You can also subscribe to our monthly magazine, DOTmed Business News, for free.
The Brotherhood of the Balloon (BOB) is a group of prostate cancer patients who have chosen conformal proton beam radiation therapy (proton treatment). The organization was formed in December 2000 by Bob Marckini and several other patients of the Loma Linda University Medical Proton Treatment Center. Today we have more than 8,000 members from all 50 states and 39 different countries. Members represent all operating proton centers in the U.S. as well as four proton centers in Europe and Asia. Financial support for the BOB is provided by Loma Linda University Cancer Center.